Literature DB >> 19182564

Results of the STAR*D study: implications for clinicians and drug developers.

Sheldon H Preskorn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19182564     DOI： 10.1097/01.pra.0000344918.51404.1e

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN： 1527-4160            Impact factor:   1.325


× No keyword cloud information.
  4 in total

1.  Current nosology of treatment resistant depression: a controversy resistant to revision.

Authors:  Michele Fornaro; Patricia Giosuè
Journal:  Clin Pract Epidemiol Ment Health       Date:  2010-05-04

Review 2.  Current place of monoamine oxidase inhibitors in the treatment of depression.

Authors:  Kenneth I Shulman; Nathan Herrmann; Scott E Walker
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

3.  An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects.

Authors:  Michele Fornaro; Matteo Martino; Bruna Dalmasso; Salvatore Colicchio; Marzia Benvenuti; Giulio Rocchi; Andrea Escelsior; Giulio Perugi
Journal:  Ann Gen Psychiatry       Date:  2011-09-19       Impact factor: 3.455

4.  Prediction of individual response to antidepressants and antipsychotics: an integrated concept.

Authors:  Sheldon H Preskorn
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.